Cambrex has expanded its stability storage business, Q1 Scientific, in Ireland and Belgium.
Cambrex announced on Oct. 4, 2022 the expansion of Q1 Scientific, its stability storage business, which offers environmentally controlled stability storage services to the pharmaceutical, medical device, and life sciences industries. Its existing facility in Waterford, Ireland will have an additional 10,000 ft2 expansion, and a new 20,000 ft2 current good manufacturing practices (CGMP) facility will be opened in Belgium.
The new temperature-controlled and monitored storage facility in Belgium will be located in the Liege region. The facility will provide 35,000 temperature-controlled storage spaces. The Waterford-based Ireland facility has doubled in size over the past two years and continues to grow with this new 10,000 ft2 expansion.
“With Cambrex’s scientific expertise and scale, we are able to accelerate our growth plans and launch a second site in 2023,” said Stephen Delaney, managing director of Q1 Scientific, in a company press release. “Operating two sites will be a great benefit to our European customers, who can now expect even faster turnaround times for the return of samples. Meanwhile, we will also be able to provide greater temperature-controlled transport options in mainland Europe.”
Source: Cambrex
Exosomes Field Advances with Milestones Achieved by EXO Biologics and ExoXpert
December 4th 2024EXO Biologics and ExoXpert, an EXO Biologics subsidiary, have received GMP certification of a European manufacturing facility for exosomes and have successfully loaded mRNA and DNA payloads into GMP-grade exosomes for drug delivery.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.